Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Which Is More Suitable For Aggressive Investors Index Fund Vs Target Date weighs volatility, potential upside, and suitability for growth-focused plans.
28,574 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
XRP’s liquidity on Binance has cratered to levels not seen since early 2020, masking a calm price as traders brace fo...
SCHB and VTV offer low-cost ways to invest in U.S. stocks, but they serve different purposes. One captures the broad ...
Oil prices have slipped below $70 even as shipping tensions threaten the Strait of Hormuz. This guide explains what d...
A little-known income ETF has doubled this year by selling covered calls on AMD, outperforming the broad market as th...
Investors aiming for $2,500 in monthly income must weigh big upfront costs, inflation risk, and price volatility as y...
A Qualys director recently sold shares worth about $104,000 in an open-market move. Learn how to interpret insider sa...
The latest CPI data shows inflation moving in a way it hasn’t in years. This could shift Fed policy and rock the stoc...
June data from the National Association of Realtors shows pending home sales fall 5.4% month over month, reflecting a...
Crypto traders are watching SpaceX’s near-public listing for signs that pre-IPO perpetual futures could become a majo...
A recent filing shows Meros Investment Management sold a sizable block of Photronics shares. Learn what this kind of ...
A major hedge fund just sold its entire Abercrombie & Fitch stake. Here’s what that means for investors, how to inter...